Cardiac dysfunction and prenatal exposure to venlafaxine

Venlofaxine, a widely used antidepressant, is known to cause a withdrawal syndrome. We present a case of neonatal transient ventricular dysfunction in a neonate exposed to venlafaxine in utero. Other causes of ventricular dysfunction were excluded. Neonatal ventricular dysfunction can be a possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Ana R, Marçal, Mónica, Tuna, Madalena, Anjos, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831389/
https://www.ncbi.nlm.nih.gov/pubmed/27099733
http://dx.doi.org/10.1002/ccr3.412
_version_ 1782427063776444416
author Araújo, Ana R
Marçal, Mónica
Tuna, Madalena
Anjos, Rui
author_facet Araújo, Ana R
Marçal, Mónica
Tuna, Madalena
Anjos, Rui
author_sort Araújo, Ana R
collection PubMed
description Venlofaxine, a widely used antidepressant, is known to cause a withdrawal syndrome. We present a case of neonatal transient ventricular dysfunction in a neonate exposed to venlafaxine in utero. Other causes of ventricular dysfunction were excluded. Neonatal ventricular dysfunction can be a possible side effect of maternal use of this drug.
format Online
Article
Text
id pubmed-4831389
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48313892016-04-20 Cardiac dysfunction and prenatal exposure to venlafaxine Araújo, Ana R Marçal, Mónica Tuna, Madalena Anjos, Rui Clin Case Rep Case Reports Venlofaxine, a widely used antidepressant, is known to cause a withdrawal syndrome. We present a case of neonatal transient ventricular dysfunction in a neonate exposed to venlafaxine in utero. Other causes of ventricular dysfunction were excluded. Neonatal ventricular dysfunction can be a possible side effect of maternal use of this drug. John Wiley and Sons Inc. 2016-03-03 /pmc/articles/PMC4831389/ /pubmed/27099733 http://dx.doi.org/10.1002/ccr3.412 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Araújo, Ana R
Marçal, Mónica
Tuna, Madalena
Anjos, Rui
Cardiac dysfunction and prenatal exposure to venlafaxine
title Cardiac dysfunction and prenatal exposure to venlafaxine
title_full Cardiac dysfunction and prenatal exposure to venlafaxine
title_fullStr Cardiac dysfunction and prenatal exposure to venlafaxine
title_full_unstemmed Cardiac dysfunction and prenatal exposure to venlafaxine
title_short Cardiac dysfunction and prenatal exposure to venlafaxine
title_sort cardiac dysfunction and prenatal exposure to venlafaxine
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831389/
https://www.ncbi.nlm.nih.gov/pubmed/27099733
http://dx.doi.org/10.1002/ccr3.412
work_keys_str_mv AT araujoanar cardiacdysfunctionandprenatalexposuretovenlafaxine
AT marcalmonica cardiacdysfunctionandprenatalexposuretovenlafaxine
AT tunamadalena cardiacdysfunctionandprenatalexposuretovenlafaxine
AT anjosrui cardiacdysfunctionandprenatalexposuretovenlafaxine

Ejemplares similares